F

or the third time in six months, Pfizer (PFE) is having difficulty manufacturing certain prefilled syringes of opioid painkillers — and the ongoing supply problems are upsetting hospitals around the country.

The string of difficulties are all occurring at a specific plant that has recently encountered manufacturing issues, although the latest snag with the Carpuject and iSecure syringes is being traced to a component made by a supplier, according to a Jan. 31 letter that Pfizer sent to its customers.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.